본문으로 건너뛰기
← 뒤로

Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from in Triple-Negative Breast Cancer.

1/5 보강
Biomacromolecules 📖 저널 OA 35% 2024: 2/2 OA 2025: 3/6 OA 2026: 2/12 OA 2024~2026 2026 Vol.27(1) p. 702-715
Retraction 확인
출처

Li Z, Saravanakumar K, Yao L, Kim Y, Jo J, Choi SY

📝 환자 설명용 한 줄

Cyclopeptides are promising anticancer agents due to their ability to regulate multiple signaling pathways.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Li Z, Saravanakumar K, et al. (2026). Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from in Triple-Negative Breast Cancer.. Biomacromolecules, 27(1), 702-715. https://doi.org/10.1021/acs.biomac.5c01953
MLA Li Z, et al.. "Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from in Triple-Negative Breast Cancer.." Biomacromolecules, vol. 27, no. 1, 2026, pp. 702-715.
PMID 41457563 ↗

Abstract

Cyclopeptides are promising anticancer agents due to their ability to regulate multiple signaling pathways. In this study, a novel cyclopeptide, Asiminatide A (AA), was isolated from , and a nanodrug delivery system (nDDS) was developed to enhance its efficacy against triple-negative breast cancer (TNBC). High-resolution time-of-flight mass spectrometer (HR-TOF-MS) and H/C NMR analyses identified AA as a cyclic heptapeptide composed of Pro-Val-Phe-Ile-Ser-Ile-Gly. AA was encapsulated into folic-acid-conjugated chitosan nanoparticles (AA-FA-CS NPs), as confirmed by H NMR and Fourier-transform infrared spectroscopy (FTIR). The nanoparticles exhibited pH-responsive drug release with enhanced release at pH 5.2. studies showed that dual pH- and folate receptor-targeted delivery significantly enhanced cytotoxicity in MDA-MB-231 cells via oxidative stress and nuclear damage while maintaining good biocompatibility. , AA-FA-CS NPs effectively suppressed tumor growth without any evident organ toxicity. These results demonstrate the anticancer potential of AA enabled by nanodelivery.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반